Arginine-chitosan- and Arginine-polyethylene glycol-conjugated superparamagnetic nanoparticles: Preparation, cytotoxicity and controlled-release

Journal of Biomaterials Applications

Volumn 29, Issue 2, 2014, Pages 186-198

  Hussein Al Ali, Samer Hasan ^a   Arulselvan, Palanisamy ^a   Fakurazi, Sharida ^a   Hussein, Mohd Zobir ^a   Dorniani, Dena ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

Author keywords

Arginine; cell lines; iron oxide magnetic nanoparticles; superparamagnetism

Indexed keywords

BIOCOMPATIBILITY; CELL CULTURE; CHITOSAN; CYTOTOXICITY; DRUG DELIVERY; FOURIER TRANSFORM INFRARED SPECTROSCOPY; IRON OXIDES; NANOCOMPOSITES; NANOPARTICLES; POLYETHYLENE GLYCOLS; SUPERPARAMAGNETISM; THERMOGRAVIMETRIC ANALYSIS; X RAY DIFFRACTION;

CELL LINES; MAGNETIC NANO-PARTICLES; MAGNETIC NANOPARTI CLES (MNPS); MOUSE EMBRYONIC FIBROBLASTS; POLYETHYLENE GLYCOL (PEG); PSEUDO-SECOND-ORDER KINETIC MODELS; SUPERPARAMAGNETIC NANOPARTICLES; TARGETED DRUG DELIVERY SYSTEMS;

ARGININE;

ARGININE; CHITOSAN; MACROGOL; MAGNETIC NANOPARTICLE; NANOCOMPOSITE; NANOPARTICLE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE;

ARTICLE; CERVICAL CANCER CELL LINE; CONTROLLED RELEASE FORMULATION; CYTOTOXICITY; DRUG SYNTHESIS; FEMALE; HUMAN; HUMAN CELL; IC 50; INFRARED SPECTROSCOPY; PRIORITY JOURNAL; THERMOGRAVIMETRY; X RAY DIFFRACTION;

EID: 84904317251     PISSN: 08853282     EISSN: 15308022     Source Type: Journal    
DOI: 10.1177/0885328213519691     Document Type: Article

References (48)

1. Wang Y-XJ, Hussain SM, Krestin GP. Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging. Eur Radiol. 2001 ; 11: 2319-2331 (Pubitemid 33041104)
2. Mahmoudi M, Simchi A, Milani AS, et al. Cell toxicity of superparamagnetic iron oxide nanoparticles. J Colloid Interf Sci. 2009 ; 336: 510-518
3. Xu ZP, Zeng QH, Lu GQ, et al. Inorganic nanoparticles as carriers for efficient cellular delivery. Chem Eng Sci. 2006 ; 61: 1027-1040 (Pubitemid 41650188)
4. Chen Y-C, Min C-N, Wu H-C, et al. In vitro evaluation of the l-peptide modified magnetic lipid nanoparticles as targeted magnetic resonance imaging contrast agent for the nasopharyngeal cancer. J Biomater Appl. 2012 ; 28: 580-594
5. Kumar CS, Mohammad F. Magnetic nanomaterials for hyperthermia-based therapy and controlled drug delivery. Adv Drug Delivery Rev. 2011 ; 63: 789-808
6. Li Z, Kawashita M, Araki N, et al. Preparation of magnetic iron oxide nanoparticles for hyperthermia of cancer in a FeCl2-NaNO3-NaOH aqueous system. J Biomater Appl. 2011 ; 25: 643-661
7. Zheng SW, Huang M, Hong RY, et al. RGD-conjugated iron oxide magnetic nanoparticles for magnetic resonance imaging contrast enhancement and hyperthermia. J Biomater Appl. :
8. Yilmaz A, Rosch S, Klingel K, et al. Magnetic resonance imaging (MRI) of inflamed myocardium using iron oxide nanoparticles in patients with acute myocardial infarction-preliminary results. Int J Cardiol. 2011 ; 163: 175-182
9. Dung TT, Danh TM, Duc NH, et al. Preparation and characterization of magnetic nanoparticles coated with polyethylene glycol. J Phys Conf Ser. 2009 ; 187: 012048-012048
10. Tartaj P, del Puerto Morales M, Veintemillas-Verdaguer S, et al. The preparation of magnetic nanoparticles for applications in biomedicine. J Phys D Appl Phys. 2003 ; 36: R182 - R182
11. Chomoucka J, Drbohlavova J, Babula P, et al. Cell toxicity and preparation of streptavidin-modified iron nanoparticles and glutathione-modified cadmium-based quantum dots. Procedia Eng. 2010 ; 5: 922-925
12. Jain TK, Morales MA, Sahoo SK, et al. Iron oxide nanoparticles for sustained delivery of anticancer agents. Mol Pharm. 2005 ; 2: 194-205 (Pubitemid 40917416)
13. Unsoy G, Yalcin S, Khodadust R, et al In:Nanocon. Brno: Czech Republic ; 2012 :
14. Kaaki K, Herve-Aubert K, Chiper M, et al. Magnetic nanocarriers of doxorubicin coated with poly(ethylene glycol) and folic acid: relation between coating structure, surface properties, colloidal stability, and cancer cell targeting. Langmuir. 2011 ; 28: 1496-1505
15. Kayal S, Ramanujan RV. Doxorubicin loaded PVA coated iron oxide nanoparticles for targeted drug delivery. Mater Sci Eng C. 2010 ; 30: 484-490
16. Quan Q, Xie J, Gao H, et al. HSA coated iron oxide nanoparticles as drug delivery vehicles for cancer therapy. Mol Pharm. 2011 ; 8: 1669-1676
17. Saboktakin MR, Tabatabaie R, Maharramov A, et al. Synthesis and characterization of superparamagnetic chitosan-dextran sulfate hydrogels as nano carriers for colon-specific drug delivery. Carbohydr Polym. 2010 ; 81: 372-376
18. Finotelli PV, Da Silva D, Sola-Penna M, et al. Microcapsules of alginate/chitosan containing magnetic nanoparticles for controlled release of insulin. Colloids Surf B Biointerfaces. 2010 ; 81: 206-211
19. Qu J-B, Shao H-h, Jing G-L, et al. PEG-chitosan-coated iron oxide nanoparticles with high saturated magnetization as carriers of 10-hydroxycamptothecin: preparation, characterization and cytotoxicity studies. Colloids Surf B Biointerfaces. 2013 ; 102: 37-44
20. Dorniani D, Hussein MZB, Kura AU, et al. Preparation of Fe3O4 magnetic nanoparticles coated with gallic acid for drug delivery. Int J Nanomed. 2012 ; 7: 5745-5745
21. Sun C, Sze R, Zhang M. Folic acid-PEG conjugated superparamagnetic nanoparticles for targeted cellular uptake and detection by MRI. J Biomed Mater Res A. 2006 ; 78: 550-557 (Pubitemid 44253539)
22. Hussein-Al-Ali SH, Zowalaty MEE, Hussein MZ, et al. Novel kojic acid-polymer-based magnetic nanocomposites for medical applications. Int J Nanomed. 2013 ; 8 :
23. Hussein-Al-Ali SH, Zowalaty ME, Hussein MZ, et al. Synthesis, characterization, controlled release, and in vitro antimicrobial studies of a novel streptomycin chitosan magnetic nanoantibiotic. Int J Nanomed. 2013 ; 8 :
24. Hussein-Al-Ali SH, Arulseivanp P, Hussein MZ, et al. Synthesis, characterization, controlled release and cytotoxicity effect studies of anthranilic acid loaded chitosan and polyethylene glycol-magnetic nanoparticles on murine macrophage raw 264.7 cells. Nano. 2013 ; 9 :
25. Rhodes PM, Leone AM, Francis PL, et al. The l-arginine: nitric oxide pathway is the major source of plasma nitrite in fasted humans. Biochem Biophys Res Commun. 1995 ; 209: 590-596
26. Ignarro L NO more heart disease: how nitric oxide can prevent - even reverse - heart disease and stroke. New York: St. Martin's Press ; 2006 :
27. Shukla J, Thakur VS, Poduval TB. Arginine: appropriate dose and delivery environment makes it an anticancer molecule. Open Cancer J. 2010 ; 3: 1-15
28. Zhu Y, Wu Q. Synthesis of magnetite nanoparticles by precipitation with forced mixing. J Nanopart Res. 1999 ; 1: 393-396 (Pubitemid 129636199)
29. Kuznetsov AA, Filippov VI, Kuznetsov OA, et al. New ferro-carbon adsorbents for magnetically guided transport of anti-cancer drugs. J Magn Magn Mater. 1999 ; 194: 22-30
30. Glover AL, Bennett JB, Pritchett JS, et al. Magnetic heating of iron oxide nanoparticles and magnetic micelles for cancer therapy. IEEE Trans Magn. 2013 ; 49: 231-235
31. Yu S, Chow GM. Carboxyl group (-CO2H) functionalized ferrimagnetic iron oxide nanoparticles for potential bio-applications. J Mater Chem. 2004 ; 14: 2781-2786
32. Marchessault RH, Ravenelle F, Zhu XX Polysaccharides for drug delivery and pharmaceutical applications. An American Chemical Society Publication ; 2006, pp.368, Symposium Series :
33. Unsoy G, Yalcin S, Khodadust R, et al. Synthesis optimization and characterization of chitosan-coated iron oxide nanoparticles produced for biomedical applications. J Nanopart Res. 2012 ; 14: 1-13
34. Shameli K, Bin Ahmad M, Jazayeri SD, et al. Synthesis and characterization of polyethylene glycol mediated silver nanoparticles by the green method. Int J Mol Sci. 2012 ; 13: 6639-6650
35. Gupta AK, Wells S. Surface-modified superparamagnetic nanoparticles for drug delivery: preparation, characterization, and cytotoxicity studies. IEEE Trans Nanobiosci. 2004 ; 3: 66-73
36. Li H-b, Lin Z-j, Luo Y. Local structures and chemical properties of deprotonated arginine. Chin J Chem Phys. 2012 ; 25: 681-681
37. Alexiou C, Arnold W, Hulin P, et al. Magnetic mitoxantrone nanoparticle detection by histology, X-ray and MRI after magnetic tumor targeting. J Magn Magn Mater. 2001 ; 225: 187-193 (Pubitemid 32335295)
38. Inbaraj BS, Tsai T-Y, Chen B-H. Synthesis, characterization and antibacterial activity of superparamagnetic nanoparticles modified with glycol chitosan. Sci Technol Adv Mater. 2012 ; 13: 015002-015002
39. Dilnawaz F, Singh A, Mohanty C, et al. Dual drug loaded superparamagnetic iron oxide nanoparticles for targeted cancer therapy. Biomaterials. 2010 ; 31: 3694-3706
40. Chen J-P, Yang P-C, Ma Y-H, et al. Characterization of chitosan magnetic nanoparticles for in situ delivery of tissue plasminogen activator. Carbohydr Polym. 2011 ; 84: 364-372
41. Qu J-B, Shao H-h, Jing G-L, et al. PEG-chitosan-coated iron oxide nanoparticles with high saturated magnetization as carriers of 10-hydroxycamptothecin: preparation, characterization and cytotoxicity studies. Colloids Surf B. 2013 ; 102: 37-44
42. Zhu A, Yuan L, Liao T. Suspension of Fe3O4 nanoparticles stabilized by chitosan and o-carboxymethylchitosan. Int J Pharm. 2008 ; 350: 361-368
43. Kumar R, Inbaraj BS, Chen BH. Surface modification of superparamagnetic iron nanoparticles with calcium salt of poly(l-glutamic acid) as coating material. Mater Res Bull. 2010 ; 45: 1603-1607
44. Shan Z, Yang W-S, Zhang X, et al. Preparation and characterization of carboxyl-group functionalized superparamagnetic nanoparticles and the potential for bio-applications. J Brazil Chem Soc. 2007 ; 18: 1329-1335
45. Yue-Jian C, Juan T, Fei X, et al. Synthesis, self-assembly, and characterization of PEG-coated iron oxide nanoparticles as potential MRI contrast agent. Drug Dev Ind Pharm. 2010 ; 36: 1235-1244
46. Dong L, Yan L, Hou W-G, et al. Synthesis and release behavior of composites of camptothecin and layered double hydroxide. J Solid State Chem. 2010 ; 183: 1811-1816
47. Ho Y-S, Ofomaja AE. Pseudo-second-order model for lead ion sorption from aqueous solutions onto palm kernel fiber. J Hazard Mater. 2006 ; 129: 137-142
48. Sakore S, Chakraborty B. Formulation and evaluation of enalapril maleate sustained release matrix tablets. Int J Pharm. 2013 ; 4: 21-26